Unilife Corporation(NASDAQ : UNIS)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading UNIS News...
Health Technology » Medical Specialties
|BSX||Boston Scientific Corporation||-2.57%||22.38||1.6%||$277.08m|
|ZBH||Zimmer Biomet Holdings, Inc.||-3.59%||116.58||3.3%||$254.75m|
|BAX||Baxter International Inc.||-4.55%||43.87||21.8%||$221.40m|
|STJ||St. Jude Medical, Inc.||-2.04%||76.89||1.7%||$217.54m|
|TMO||Thermo Fisher Scientific Inc.||-4.50%||145.30||1.0%||$193.60m|
|ISRG||Intuitive Surgical, Inc.||-2.50%||644.82||3.0%||$188.93m|
|EW||Edwards Lifesciences Corporation||-3.09%||96.02||1.7%||$148.65m|
|BDX||Becton, Dickinson and Company||-3.21%||166.66||1.5%||$138.12m|
|XRAY||DENTSPLY International Inc.||-4.53%||61.30||5.4%||$115.41m|
|BCR||C. R. Bard, Inc.||-1.96%||226.16||1.5%||$102.90m|
|LDRH||LDR Holding Corporation||0.00%||37.03||8.3%||$86.71m|
Unilife Corp. designs, develops, manufactures and supplies injectable drug delivery systems. The company builds long-term collaborations with pharmaceutical and biotechnology companies seeking to utilize its innovative and differentiated devices to enable or enhance the clinical development, regulatory approval and lifecycle management of their injectable therapies. Its lead product is the Unifill ready-to-fill syringe, which is designed to be supplied to pharmaceutical manufacturers in a form that is ready for filling with their injectable drugs and vaccines. Unilife was founded by Alan D. Shortall in 2001 and is headquartered in York, PA.